GO:0032957 inositol trisphosphate metabolic process: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032957 (inositol trisphosphate metabolic process) describes the chemical reactions and pathways involving myo-inositol phosphate with three phosphate groups, principally the second messenger IP3 (inositol 1,4,5-trisphosphate).
• IP3 is generated by phospholipase C-mediated hydrolysis of phosphatidylinositol 4,5-bisphosphate and is terminated by dephosphorylation or phosphorylation, making it a tightly controlled metabolic node.
• The primary downstream effector is the IP3 receptor (ITPR1/2/3), a calcium channel on the endoplasmic reticulum that releases Ca2+ and shapes cytosolic calcium signals.
• Dysregulated IP3 metabolism and IP3 receptor function are implicated in cardiac disease, neurodegeneration, cancer, and metabolic disorders.
• Key experimental approaches include live-cell Ca2+ imaging, IP3 biosensors, receptor mutagenesis, and CRISPR-based knockout or knock-in models.
• EDITGENE provides CRISPR knockout, point-mutation, knock-in, overexpression cell models and library screening/bioinformatics to dissect IP3 metabolic genes.
Description
Inositol trisphosphate metabolic process (GO:0032957) is the biological process encompassing the chemical reactions and pathways that produce, interconvert, and degrade myo-inositol phosphate molecules bearing three phosphate groups, most notably D-myo-inositol 1,4,5-trisphosphate (IP3). IP3 is a classical second messenger generated when phospholipase C cleaves phosphatidylinositol 4,5-bisphosphate in response to diverse extracellular stimuli, and its levels are controlled by a balance of synthesis and metabolic removal. Because IP3 directly gates the IP3 receptor (ITPR) calcium channels on the endoplasmic reticulum, this metabolic process is a central determinant of intracellular Ca2+ signaling amplitude, duration, and spatial patterning. Researchers study GO:0032957 because it sits at the intersection of signal transduction, calcium homeostasis, and lipid metabolism, and because perturbations in IP3 metabolism are linked to human disease. The process is not a single linear pathway but a network of enzymatic reactions, including phospholipase C-mediated formation, 5-phosphatase and 3-kinase-mediated inactivation, and further dephosphorylation to inositol bisphosphate and inositol monophosphate. Understanding which enzymes and receptors control IP3 turnover is therefore essential for interpreting calcium-dependent physiology and for designing targeted interventions.
inositol trisphosphate metabolic process At A Glance
| GO ID | GO:0032957 |
|---|---|
| GO term | inositol trisphosphate metabolic process |
| Ontology | biological_process |
| Synonym | inositol trisphosphate metabolism; IP3 metabolic process; IP3 metabolism; myo-inositol trisphosphate metabolic process |
| Major function | Production, interconversion, and degradation of inositol trisphosphate second messengers, chiefly IP3, controlling calcium signaling |
| Key enzymes | Phospholipase C isoforms, IP3 3-kinases, IP3 5-phosphatases, inositol polyphosphate phosphatases |
| Key receptors | ITPR1, ITPR2, ITPR3 (IP3 receptors) |
| Cellular location | Plasma membrane, cytosol, endoplasmic reticulum membrane |
| Related disease areas | Cardiac arrhythmia, neurodegeneration, cancer, metabolic disorders |
What Is GO:0032957?
GO:0032957, inositol trisphosphate metabolic process, is defined as the chemical reactions and pathways involving myo-inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with three phosphate groups attached. In practice, this includes the synthesis of IP3 from membrane phosphoinositides, its phosphorylation or dephosphorylation to other inositol phosphates, and its eventual degradation, all of which determine the availability of IP3 for receptor-mediated calcium release.
Why Is inositol trisphosphate metabolic process Important in Cell Biology?
GO:0032957 is important because IP3 is one of the most widely used second messengers in eukaryotic cells, and its metabolic balance directly sets the gain of calcium signaling pathways that control secretion, contraction, gene expression, and cell survival. Altering IP3 production or degradation changes the spatiotemporal pattern of Ca2+ release, which can switch physiological signaling into pathological states such as arrhythmia, neurodegeneration, or uncontrolled proliferation. Consequently, the enzymes and receptors that define this process are both mechanistic hubs and candidate therapeutic targets.
• IP3 metabolism controls cytosolic Ca2+ oscillations that regulate secretion, contraction, and gene transcription.
• IP3 receptors (ITPR1/2/3) are the principal effectors linking IP3 levels to ER calcium release.
• Altered IP3 signaling is implicated in cardiac hypertrophy and arrhythmia.
• IP3 receptor dysfunction contributes to neurodegenerative conditions such as spinocerebellar ataxia and Alzheimer-related calcium dysregulation.
• IP3 metabolic enzymes influence cancer cell proliferation, apoptosis, and migration.
• Astrocytic IP3-mediated Ca2+ mobilization is important for neuron-glia communication.
• IP3 metabolism intersects with lipid homeostasis and hepatic metabolic regulation.
• Non-IP3 IP3-binding proteins expand the functional reach of IP3 beyond canonical receptors.
• The pathway is a validated target for pharmacological modulation of calcium signaling.
• CRISPR models of IP3 metabolic genes enable causal testing of disease hypotheses.
What Happens During inositol trisphosphate metabolic process?
Synthesis of IP3 from phosphoinositides
In simple terms: The cell cuts a membrane lipid to release IP3, a small messenger molecule.
IP3 is produced when phospholipase C hydrolyzes phosphatidylinositol 4,5-bisphosphate at the plasma membrane, generating IP3 and diacylglycerol. This reaction is triggered by G protein-coupled receptors and receptor tyrosine kinases and is the entry point for the IP3 arm of the phosphoinositide signaling system. The newly formed IP3 is soluble and diffuses into the cytosol to reach its receptors.
IP3 receptor binding and calcium release
In simple terms: IP3 binds a channel on the ER and opens it, letting calcium out.
Cytosolic IP3 binds to IP3 receptors (ITPR1, ITPR2, ITPR3), ligand-gated calcium channels on the endoplasmic reticulum, causing conformational changes that open the channel and release stored Ca2+ into the cytosol. The resulting calcium signal can be oscillatory or sustained depending on IP3 concentration and receptor regulation. This step is the principal functional output of GO:0032957.
Inactivation by phosphorylation and dephosphorylation
In simple terms: Enzymes chemically modify IP3 so it can no longer open calcium channels.
IP3 is terminated by two main routes: phosphorylation by IP3 3-kinases to inositol 1,3,4,5-tetrakisphosphate, and dephosphorylation by 5-phosphatases to inositol 1,4-bisphosphate. These reactions lower the effective IP3 concentration and contribute to signal termination and recycling of inositol. The balance between these routes shapes the duration of calcium release.
Further dephosphorylation and inositol recycling
In simple terms: The breakdown products are trimmed down and reused to rebuild membrane lipids.
Inositol bisphosphate and inositol monophosphate are further dephosphorylated by inositol polyphosphate phosphatases, ultimately yielding free inositol that can re-enter phosphatidylinositol synthesis. This recycling arm is essential for maintaining phosphoinositide pools and for sustained signaling capacity. It also links IP3 metabolism to broader lipid and inositol homeostasis.
Spatial and temporal organization of IP3 signals
In simple terms: The cell controls where and when IP3 acts, not just how much is made.
IP3 metabolism is spatially organized, with synthesis at the plasma membrane, diffusion through the cytosol, and action at ER receptors, creating local calcium microdomains. Astrocytic IP3-mediated Ca2+ mobilization illustrates how this spatial control supports intercellular communication. Receptor plasticity and accessory proteins further tune the response to IP3.
Key Genes Involved in GO:0032957 inositol trisphosphate metabolic process
The following genes and proteins are central to inositol trisphosphate metabolic process and its downstream signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLCB1 | Phospholipase C beta 1; generates IP3 from PIP2 | G protein-coupled receptor signaling; neuronal calcium signaling |
| PLCG1 | Phospholipase C gamma 1; generates IP3 downstream of tyrosine kinases | Cancer signaling and growth factor responses |
| ITPR1 | IP3 receptor type 1; ER calcium channel | Neurodegeneration, spinocerebellar ataxia, calcium signaling |
| ITPR2 | IP3 receptor type 2; ER calcium channel | Exocrine secretion and cardiac physiology |
| ITPR3 | IP3 receptor type 3; ER calcium channel | Immune and epithelial calcium signaling |
| ITPKA | IP3 3-kinase A; phosphorylates IP3 | Termination of IP3 signals; neuronal function |
| ITPKB | IP3 3-kinase B; phosphorylates IP3 | Immune cell signaling and IP3 turnover |
| ITPKC | IP3 3-kinase C; phosphorylates IP3 | Inositol phosphate metabolism and disease associations |
| INPP5A | Inositol polyphosphate 5-phosphatase; degrades IP3 | Signal termination and cancer |
| INPP5B | Inositol polyphosphate 5-phosphatase | Phosphoinositide turnover |
| OCRL | Inositol polyphosphate 5-phosphatase | Lowe syndrome; phosphoinositide metabolism |
| SYNJ1 | Synaptojanin 1; polyphosphoinositide phosphatase | Synaptic vesicle recycling and IP3 turnover |
| IMPA1 | Inositol monophosphatase 1 | Inositol recycling; lithium-sensitive pathway |
| IMPA2 | Inositol monophosphatase 2 | Inositol homeostasis and psychiatric genetics |
| ORM2 | Orosomucoid 2; modulates hepatic lipid metabolism | Links IP3-related metabolic signaling to lipogenesis |
| PITPNM1 | Phosphatidylinositol transfer protein | Phosphoinositide supply for IP3 synthesis |
| CALM1 | Calmodulin; regulates IP3 receptors and Ca2+ feedback | Calcium-dependent modulation of IP3 signaling |
How Is inositol trisphosphate metabolic process Regulated?
IP3 metabolic process is regulated at multiple levels. Receptor activation determines phospholipase C activity and thus IP3 synthesis rate. IP3 3-kinases and 5-phosphatases set the rate of IP3 removal, and their expression or activity can shift the balance between signaling and termination. Calcium itself feeds back on IP3 receptors, producing biphasic regulation that underlies calcium oscillations. IP3 receptor plasticity, including modulation by accessory proteins and post-translational modifications, further tunes the response. In addition, metabolic signals such as those involving ORM2 can influence lipid pathways that intersect with phosphoinositide metabolism.
inositol trisphosphate metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ITPR1 | Spinocerebellar ataxia, neurodegeneration | Knock-in of patient mutations in iPSC-derived neurons |
| ITPR2 | Cardiac arrhythmia and hypertrophy | Cardiomyocyte knockout and calcium imaging |
| PLCB1 | Epilepsy and neuronal signaling disorders | Neuronal knockout with live-cell Ca2+ imaging |
| OCRL | Lowe syndrome | Knockout in renal epithelial cells |
| ORM2 | Hepatic lipid homeostasis | Overexpression and knockout in hepatocytes |
Cardiac disease and arrhythmia
IP3 receptors in cardiomyocytes contribute to calcium handling, and their dysregulation has been linked to hypertrophy, arrhythmia, and heart failure. Because IP3 metabolism controls the amount of ligand available to these receptors, altered IP3 turnover can change cardiac calcium signaling and electrical stability.
Neurodegeneration and neurological disorders
ITPR1 mutations and altered IP3 receptor function are associated with spinocerebellar ataxia and other neurological phenotypes, and IP3-mediated calcium signals are important in neurons and astrocytes. Disrupted IP3 metabolism may therefore contribute to calcium dyshomeostasis in neurodegenerative disease.
Cancer
IP3 signaling influences proliferation, survival, and migration, and components of IP3 metabolism are altered in various cancers. IP3 receptors and metabolic enzymes can support pro-tumorigenic calcium signals, making this pathway a candidate for therapeutic targeting.
Metabolic and hepatic disorders
IP3-related signaling intersects with lipid metabolism, and ORM2 has been shown to maintain hepatic lipid homeostasis by suppressing de novo lipogenesis. This suggests that IP3 metabolic pathways may be relevant to metabolic disease contexts.
From inositol trisphosphate metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of an IP3-metabolizing enzyme alter calcium oscillations? | CRISPR knockout cell line with live-cell Ca2+ imaging |
| Does a disease-associated point mutation change IP3 receptor gating? | Point-mutation knock-in via CRISPR |
| Can a fluorescent tag report IP3 receptor localization? | Tagged knock-in of ITPR1 |
| Does overexpression of a 5-phosphatase reduce IP3 signaling? | Overexpression cell model |
| Which genes modify IP3-dependent proliferation? | CRISPR library screening |
| How does IP3 metabolism change in astrocytes? | Primary astrocyte cultures and Ca2+ biosensors |
How to Study the inositol trisphosphate metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell Ca2+ imaging | Cytosolic calcium changes | IP3-evoked ER calcium release |
| FRET IP3 biosensor | Intracellular IP3 dynamics | Real-time IP3 production and degradation |
| CRISPR knockout | Loss-of-function phenotype | Testing necessity of IP3 metabolic genes |
| CRISPR knock-in | Mutant protein behavior | Disease variant modeling |
| Inositol phosphate profiling | Levels of IP3 and metabolites | Enzyme activity and pathway flux |
| Patch-clamp electrophysiology | Ion channel activity | IP3 receptor gating studies |
| RNA-seq | Transcriptional changes | Downstream consequences of IP3 perturbation |
| Proteomics | Protein interactions and modifications | IP3 receptor complex composition |
Live-cell calcium imaging
Fluorescent Ca2+ indicators and genetically encoded biosensors allow real-time measurement of IP3-evoked calcium release in living cells, revealing oscillation frequency and amplitude. This method is central to linking IP3 metabolism to functional outcomes.
IP3 biosensors and FRET reporters
Genetically encoded IP3 sensors enable direct visualization of IP3 dynamics with spatial and temporal resolution. These tools help distinguish changes in IP3 production from changes in receptor sensitivity.
CRISPR-based genetic perturbation
Knockout, point-mutation, and knock-in models allow causal testing of specific IP3 metabolic genes and receptor variants. Combining these models with calcium imaging or biochemical assays clarifies gene function.
Biochemical and lipid assays
Measurement of inositol phosphate species by chromatography or mass spectrometry quantifies flux through IP3 metabolic reactions. Such assays complement functional calcium readouts and can reveal changes in inositol recycling.
How CRISPR Can Be Used to Study GO:0032957 inositol trisphosphate metabolic process
Knockout
CRISPR knockout of IP3 metabolic enzymes or receptors can establish whether a gene is required for IP3-dependent calcium signaling and downstream phenotypes. Knockout cell lines are useful for validating specificity of pharmacological tools and for identifying compensatory pathways.
Point Mutation
Point-mutation knock-in allows precise modeling of disease-associated variants in ITPR genes or metabolic enzymes, enabling comparison of gating, turnover, or binding properties. Such models help distinguish pathogenic variants from benign polymorphisms.
Knock-in
Tagged knock-in of IP3 receptors or enzymes with fluorescent or affinity tags supports localization, interaction, and dynamic studies in a native context. This approach preserves endogenous regulatory elements and expression levels.
Overexpression
Overexpression of IP3 5-phosphatases or 3-kinases can suppress IP3 signals and test sufficiency of negative regulation. Conversely, overexpression of phospholipase C isoforms can enhance IP3 production and calcium release.
How EDITGENE Supports inositol trisphosphate metabolic process Research
Researchers studying inositol trisphosphate metabolic process-related genes often need to determine whether a candidate gene is causally involved in IP3 synthesis, degradation, or receptor-mediated calcium signaling. Rigorous causal inference requires well-controlled genetic models that isolate the gene of interest without confounding off-target effects.
Contact EDITGENE today to design your custom CRISPR model for inositol trisphosphate metabolic process research.
Frequently Asked Questions About inositol trisphosphate metabolic process
What is inositol trisphosphate metabolic process?
It is the biological process (GO:0032957) comprising the chemical reactions and pathways involving myo-inositol phosphate with three phosphate groups, chiefly the synthesis and degradation of IP3.
What is the GO ID for inositol trisphosphate metabolic process?
The GO ID is GO:0032957.
What genes are involved in inositol trisphosphate metabolic process?
Key genes include PLCB1, PLCG1, ITPR1, ITPR2, ITPR3, ITPKA, ITPKB, ITPKC, INPP5A, OCRL, SYNJ1, IMPA1, and IMPA2.
How is IP3 produced?
IP3 is produced by phospholipase C-mediated hydrolysis of phosphatidylinositol 4,5-bisphosphate at the plasma membrane.
What does IP3 do in the cell?
IP3 binds IP3 receptors on the endoplasmic reticulum to release calcium into the cytosol, acting as a second messenger.
How is IP3 signal terminated?
IP3 is inactivated by 3-kinases and 5-phosphatases, and further dephosphorylated to inositol and other metabolites.
Which diseases are linked to IP3 metabolism?
Cardiac arrhythmia, neurodegeneration, cancer, and metabolic disorders have been associated with altered IP3 signaling.
What methods study IP3 metabolism?
Live-cell calcium imaging, FRET IP3 biosensors, inositol phosphate profiling, and CRISPR genetic models are commonly used.
Can CRISPR be used to study IP3 receptors?
Yes, CRISPR knockout, point-mutation, and knock-in models are used to dissect IP3 receptor function and disease variants.
Why is IP3 metabolism important for drug discovery?
Because it controls calcium signaling, modulating IP3 metabolic enzymes or receptors may correct pathological calcium handling in disease.
Conclusion
GO:0032957, inositol trisphosphate metabolic process, defines the synthesis, interconversion, and degradation of IP3, a central second messenger controlling calcium signaling. Its importance spans cardiac, neurological, oncological, and metabolic biology, and its components are tractable targets for genetic and pharmacological study. CRISPR-based models and advanced imaging continue to clarify how IP3 turnover shapes physiology and disease.
References
- 1. Berridge MJ. 2016. The Inositol Trisphosphate/Calcium Signaling Pathway in Health and Disease.. Physiol Rev 96(4):1261-96 PMID: 27512009
- 2. Zhou B et al.. 2022. Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis.. Nat Metab 4(9):1185-1201 PMID: 36050503
- 3. Mackrill JJ. 2023. Non-inositol 1,4,5-trisphosphate (IP(3)) receptor IP(3)-binding proteins.. Biochim Biophys Acta Mol Cell Res 1870(5):119470 PMID: 37011730
- 4. Parys JB et al.. 2012. Inositol 1,4,5-trisphosphate and its receptors.. Adv Exp Med Biol 740:255-79 PMID: 22453946
- 5. Demydenko K et al.. 2022. Inositol 1,4,5-trisphosphate receptors in cardiomyocyte physiology and disease.. Philos Trans R Soc Lond B Biol Sci 377(1864):20210319 PMID: 36189803
- 6. Berridge MJ. 2009. Inositol trisphosphate and calcium signalling mechanisms.. Biochim Biophys Acta 1793(6):933-40 PMID: 19010359
- 7. Hamada K et al.. 2020. IP(3) Receptor Plasticity Underlying Diverse Functions.. Annu Rev Physiol 82:151-176 PMID: 31730387
- 8. Okubo Y et al.. 2020. Visualization of astrocytic intracellular Ca(2+) mobilization.. J Physiol 598(9):1671-1681 PMID: 30825213
